ConductScience.org, home

Paper306574

Effect of acetylator phenotype on the rate at which procainamide induces antinuclear antibodies and the lupus syndrome.

Woosley RL and 5 others. N Engl J Med, 1978. Cited by 221 papers, by iCite.

Cite this record

ConductScience Library. Effect of acetylator phenotype on the rate at which procainamide induces antinuclear antibodies and the lupus syndrome. Papers, record 306574. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/306574

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effect of acetylator phenotype on the rate at which procainamide induces antinuclear antibodies and the lupus syndrome.
PubMed
Journal
N Engl J Med
PubMed
Year
1978
PubMed
Publication types
Historical Article, Journal Article, Research Support, U.S. Gov't, Non-P.H.S.
PubMed
Citations, by iCite
221
iCite
Relative citation ratio, by iCite
8.03
iCite
Revised in PubMed
2013-11-21
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Woosley RLR L
2Drayer DED E
3Reidenberg MMM M
4Nies ASA S
5Carr KK
6Oates JAJ A

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibodies, AntinuclearMajor topic
Lupus Erythematosus, SystemicMajor topic
ProcainamideMajor topic
Acetylation
Adult
Aged
Biotransformation
History, 18th Century
Humans
Middle Aged
Phenotype
Retrospective Studies
Time Factors

Source PubMed

Download CSV of topics

Cited by66

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 221 citations.

PMIDTitleJournalYearIn PapersSource
42649250Hepatic control of immunometabolism: implications for the pathogenesis, diagnosis and treatment of rheumatic diseases.Nat Rev Rheumatol2026https://conductscience.org/library/papers/42649250PubMed
38436771Mendelian randomization study on causal association of FAM210B with drug-induced lupus.Clin Rheumatol2024https://conductscience.org/library/papers/38436771PubMed
36714114Reliability and reproducibility of antinuclear antibody testing in pediatric rheumatology practice.Front Med (Lausanne)2022https://conductscience.org/library/papers/36714114PubMed
35035679Illustrative and historic cases of phenoconversion.Am J Transl Res2021https://conductscience.org/library/papers/35035679PubMed
34662650Lipoic acid supplementation associated with neural epidermal growth factor-like 1 (NELL1)-associated membranous nephropathy.Kidney Int2021https://conductscience.org/library/papers/34662650PubMed
33094670Arylamine N-acetyltransferase acetylation polymorphisms: paradigm for pharmacogenomic-guided therapy- a focused review.Expert Opin Drug Metab Toxicol2021https://conductscience.org/library/papers/33094670PubMed
31497427Clinical Characteristics of Hydralazine-induced Lupus.Cureus2019https://conductscience.org/library/papers/31497427PubMed
30135300Precision DNA demethylation ameliorates disease in lupus-prone mice.JCI Insight2018https://conductscience.org/library/papers/30135300PubMed
29870500Drug-induced lupus erythematosus: an update on drugs and mechanisms.Curr Opin Rheumatol2018https://conductscience.org/library/papers/29870500PubMed
28879482Pristane-induced lupus: considerations on this experimental model.Clin Rheumatol2017https://conductscience.org/library/papers/28879482PubMed
27652979Fragment-based discovery of a new family of non-peptidic small-molecule cyclophilin inhibitors with potent antiviral activities.Nat Commun2016https://conductscience.org/library/papers/27652979PubMed
26092827Drug-induced glomerular disease: immune-mediated injury.Clin J Am Soc Nephrol2015https://conductscience.org/library/papers/26092827PubMed
24467436Arylamine N-acetyltransferases: from drug metabolism and pharmacogenetics to drug discovery.Br J Pharmacol2014https://conductscience.org/library/papers/24467436PubMed
22387617Metabolomics reveals the metabolic map of procainamide in humans and mice.Biochem Pharmacol2012https://conductscience.org/library/papers/22387617PubMed
22300536Specific post-translational histone modifications of neutrophil extracellular traps as immunogens and potential targets of lupus autoantibodies.Arthritis Res Ther2012https://conductscience.org/library/papers/22300536PubMed
20972370Deleterious effects of reactive metabolites.Oxid Med Cell Longev2010https://conductscience.org/library/papers/20972370PubMed
20836007Pharmacogenomics: a systems approach.Wiley Interdiscip Rev Syst Biol Med2010https://conductscience.org/library/papers/20836007PubMed
20544243Acrylamine-induced autoimmune phenomena.Clin Rheumatol2010https://conductscience.org/library/papers/20544243PubMed
18748470The relationship between genetics and environment in the pathogenesis of rheumatic diseases.West J Med1979https://conductscience.org/library/papers/18748470PubMed
18679519Drug therapy considerations in arrhythmias in children.Indian Pacing Electrophysiol J2008https://conductscience.org/library/papers/18679519PubMed

See all 66 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/306574

GET https://conductscience.org/api/papers/v1/306574/cited_by?page=2